Point-Of-Care Diagnostics / Testing (POCT) Market By Product (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing), By End-User (Clinics, Home, Laboratories, Assisted Living Healthcare Facilities, Hospitals) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

This report on point-of-care diagnostics / testing (POCT) market studies various products and end-users market. POCT is considered as one of the most affordable technologies of global diagnostics market, and development in POCT technologies over period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts the factors assisting the growth of POC diagnostics market are several government initiatives have aided in the development of innovative outpatient care models, to minimize hospital stays and rapidly increasing demand for home healthcare globally.

For the purpose of this study, the global point of care diagnostics market on the basis of product type is segmented into glucose monitoring,  urinalysis testing, cardiac markers , infectious diseases testing,  cholesterol testing, coagulation monitoring , pregnancy and fertility testing, hematology testing, fecal occult testing kits, blood gas testing, cancer markers, drugs of abuse testing, and others . Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of end users point of care diagnostic market is segmented as clinics, home, laboratories, assisted living healthcare facilities and hospitals. The diagnostic tests performed on a large scale in these healthcare institutes and increasing demand for further expansion of point of care diagnostic facilities are the key factors fueling the growth of point of care diagnostics market in hospitals and clinics. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The POC diagnostics and testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The key manufacturers from point of care diagnostics market are carrying out constant efforts and huge investments on research and development of innovative products which are enabled with advanced technologies. The major key players profiled in the POC diagnostics and testing market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc.

Based on the end-users, the point-of-care diagnostics / testing (POCT) market is segmented into:

• Clinics
• Home
• Laboratories
• Assisted living healthcare facilities
• Hospitals
•  

In base year 2015, the clinics and hospitals collectively attribute the largest share in the market in terms of revenue. The diagnostic tests are carried out on a large scale in these healthcare institutes and rising demand for accessible and patient compliant diagnostics technologies are the key factors fueling the growth of POC diagnostics market in hospitals and clinics. Moreover, the aging patient base worldwide and rising demand of assisted and home healthcare technologies, the point of care diagnostic market is expected to show lucrative growth over the forecast period 2016 - 2022.

For the purpose of this study, the global point-of-care diagnostics or testing (POCT) market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In base year 2015, North America accounted for the largest share in the global POCT market, followed by Asia-Pacific, Europe, and the RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2022. The key factors assisting the growth of point-of-care diagnostics market in Asia-Pacific region are the huge patient population base, large number of R&D activities carried out in diagnostics field, rising focus of both international and domestic players on the Asia-Pacific POCT market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products.